Company intelligence / Profile preview

MindChild Medical

North Andover, Massachusetts, United Statesmindchild.com ↗

Ownership: Private
Development stage: Other

Overview

The MERIDIAN M110 system has received FDA clearance for non-invasive intrapartum fetal ECG, maternal heart rate, and uterine contraction monitoring. Clinical data published in peer-reviewed journals supports its accuracy compared to gold standard methods such as fetal scalp electrode and intrauterine pressure catheter. The system offers uninterrupted, external monitoring without the risks associated with invasive procedures.

Therapeutic areas: Women's Health
Modalities: DeviceDiagnostic equipment
Industry: Physiological Monitoring

Partnerships

Massachusetts Institute of Technology (IP licenses)Tufts Medical Center (IP licenses)E-TROLZ Inc. (IP licenses)

Beyond the preview

Go deeper on MindChild Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MindChild Medical.

Explore the full profile